Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Tvardi Therapeutics (TVRD) Return on Equity (2016 - 2025)

Tvardi Therapeutics' Return on Equity history spans 13 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity fell 2.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 2.0% decrease, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Tvardi Therapeutics, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for TVRD hit a ceiling of 0.02% in Q1 2024 and a floor of 0.1% in Q4 2023.
  • Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2021.
  • Biggest five-year swings in Return on Equity: dropped -10bps in 2023 and later increased 11bps in 2024.
  • Tracing TVRD's Return on Equity over 5 years: stood at 0.0% in 2021, then decreased by -25bps to 0.01% in 2022, then tumbled by -1922bps to 0.1% in 2023, then skyrocketed by 106bps to 0.01% in 2024, then crashed by -256bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for TVRD at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.